Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Basel Medical GroupBMGL -24.94%17 Days Inventory is 37.07 as of Dec. 2025, which is 180% above its 10-year median of 13.22. GuruFocus rates BMGL with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 497 Healthcare Providers & Services companies, Basel Medical Group ranks worse than 52.11% on this metric.
The historical rank and industry rank for Basel Medical Group's Days Inventory or its related term are showing as below:
BMGL'
s Days Inventory Range Over the Past 10 Years
Min: 11.83 Med: 13.22 Max: 39.78
Current: 31.56
During the past 4 years, Basel Medical Group's highest Days Inventory was 39.78. The lowest was 11.83. And the median was 13.22.
BMGL's Days Inventory is ranked worse than 52.11% of 497
companies
in the Healthcare Providers & Services industry
Industry Median: 29.67
vs BMGL: 31.56
Basel Medical Group's Days Inventory
increased
from Dec. 2024 (14.80) to Dec. 2025 (37.07).
It might indicate that Basel Medical Group's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Basel Medical Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 4.92.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Basel Medical Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.05.
Basel Medical Group (NAS:BMGL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Basel Medical Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Basel Medical Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Basel Medical Group Days Inventory Related Terms
Basel Medical Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Basel Medical Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BMGL vs AMS, HLYK, BICX: Days Inventory Comparison
For the Medical Care Facilities subindustry, Basel Medical Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Basel Medical Group Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Basel Medical Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Basel Medical Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Basel Medical Group (BMGL) has a Days Inventory of 37.07 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Basel Medical Group and its competitors. This is 180% above median its historical median of 13.22. Over the past decade, Basel Medical Group's Days Inventory has ranged from 11.83 to 39.78. According to the industry distribution chart, Basel Medical Group ranks #259 out of 497 companies in the Healthcare Providers & Services industry, placing it in the top 52.1%.
Is Basel Medical Group's Days Inventory too high?
Basel Medical Group's current Days Inventory of 37.07 is 180% above median its 10-year median of 13.22. Over the past 10 years, this metric has ranged from a low of 11.83 to a high of 39.78. The Healthcare Providers & Services industry median Days Inventory is 29.67. Basel Medical Group's value of 37.07 is 24.9% above this industry median. Based on the distribution chart, Basel Medical Group ranks #259 out of 497 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Basel Medical Group has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Basel Medical Group's Days Inventory compare to AMS and HLYK?
According to the Healthcare Providers & Services industry distribution chart, Basel Medical Group ranks #259 out of 497 companies for Days Inventory. This places Basel Medical Group in the lower half of its industry. The industry median Days Inventory is 29.67. Basel Medical Group's value of 37.07 is 24.9% above this benchmark. Historically, Basel Medical Group's own Days Inventory has ranged from 11.83 to 39.78 over the past decade. While the company's 10-year median is 13.22 vs. the industry median of 29.67, Basel Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.67, based on 497 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Basel Medical Group's current Days Inventory of 37.07 is 24.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Basel Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Basel Medical Group's current Days Inventory is 37.07, which is 180% above median its own 10-year median of 13.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basel Medical Group stock overvalued right now?
Basel Medical Group (BMGL) has a current Days Inventory of 37.07. The current Days Inventory is 37.07, which is 180% above median its 10-year median of 13.22 and 24.9% above the Healthcare Providers & Services industry median of 29.67. Basel Medical Group's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Basel Medical Group (BMGL), the current Days Inventory is 37.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
17GF Score
Get the complete analysis for BMGL
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMGL has been successfully added to your 
